Omeprazole and Clarithromycin With and Without Metronidazole for the Eradication of Helicobacter pylori

Chiba, Naoki
October 1996
American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2139
Academic Journal
Objectives: To treat previously untreated adult patients infected with Helicobacter pylori with one of two regimens in an ambulatory community setting to assess the efficacy and safety of these regimens. Methods: Sixty five adult patients with histologically confirmed H. pylori infection were randomly assigned in this open cohort study to 2 wk, low dose, twice daily treatment with omeprazole 20 mg and clarithromycin 250 mg (OC) (n = 31) or OC plus metronidazole 500 mg (OCM) (n = 34). At least 4 wk after treatment, H. pylori status was assessed by histology (four gastric biopsies, two each from antrum and body). Results: Triple therapy with OCM was significantly better than dual therapy with OC in intent-to-treat (82.4 vs 58.1%,p = 0.03) and per protocol analysis (93.3 vs 62.1%, p = 0.004). Although there were frequent side effects (OC 19/31 61.3%; OCM 22/34 64.7% with at least one side effect), these were generally mild, and patients were able to complete nearly all of their medications (OC 97.2%, OCM 96.7% of pills taken). The only patient withdrawn due to medication side effects was in the OC arm. Conclusions: Triple therapy with OCM in a community setting eradicates H. pylori more effectively than dual therapy with OC. OCM is tolerated with high compliance despite frequent minor side effects and appears safe without the development of serious adverse events.


Related Articles

  • A Comparison between Omeprazole-Based Triple Therapy and Bismuth-Based Triple Therapy for the Treatment of Helicobacter pylori Infection: A Prospective Randomized 1-Yr Follow-Up Study. Lerang, F.; Moum, B.; Ragnhildstveit, E.; Haug, J. B.; Hauge, T.; Tolås, P.; Aubert, E.; Henriksen, M.; Efskind, P. S.; Nicolaysen, K.; Søberg, T.; Ødegaard, A.; Berge, T. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p653 

    Objectives: To compare the efficacy and side effects of standard bismuth triple therapy with those of omeprazole-based triple therapy in patients with Helicobacter pylori infection and duodenal ulcer disease. Methods: One hundred patients were prospectively recruited and randomized to receive...

  • Clarithromycin as Monotherapy for Eradication of Helicobacter pylori: A Randomized, Double-blind Trial. Peterson, Walter I.; Graham, David Y.; Marshall, Barry; Blaser, Martin J.; Genta, Robert M.; Klein, Peter D.; Stratton, Charles W.; Drnee, James; Prokocimer, Philippe; Siepman, Nancy // American Journal of Gastroenterology;Nov1993, Vol. 88 Issue 11, p1860 

    Current regimens to eradicate Helicobacter pylori usually consist of metronidazole plus a bismuth compound, as well as a third agent such as tetracycline. Such regimens are not ideal because organisms may be metronidazole-resistant, side-effects occur, and compliance is often poor. This...

  • In Vitro Activity of Rifabutin Against Strains of Helicobacter pylori Resistant to Metronidazole and Clarithromycin. Pilotto, Alberto; Franceschi, Marilisa; Rassu, Mario; Furlan, Francesca; Scagnelli, Mariuccia // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p833 

    Provides information on a study that evaluated in vitro activity of rifabutin on 87 strains of Helicobacter pylori. Eradication rates of currently recommended treatment of Helicobacter pylori; Major reason for treatment failure and the emergence of high percentages of...

  • European Multicentre Survey of in Vitro Antimicrobial Resistance in Helicobacter pylori. Glupczynski, Y.; Mégraud, F.; Lopez-Brea, M.; Andersen, L. P. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2001, Vol. 20 Issue 11, p820 

    A multicentre in vitro survey was carried out in 1998 in 22 European centres in order to assess the variation in the prevalence of Helicobacter pylori resistance. The susceptibility of 1,274 isolates to metronidazole, clarithromycin and amoxicillin was determined by the E test. The mean rate of...

  • Comparison of the E Test and Agar Dilution Method for Antimicrobial Suceptibility Testing of Helicobacter pylori. Glupczynski, Y.; Broutet, N.; Cantagrel, A.; Andersen, L. P.; Alarcon, T.; López-Brea, M.; Mégraud, F. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2002, Vol. 21 Issue 7, p549 

    A multicentre study was carried out in order to validate the E test in comparison with the reference agar dilution method for testing the susceptibility of Helicobacter pylori to amoxicillin, clarithromycin, and metronidazole. Ten clinical isolates and one control collection isolate...

  • Secondary Resistance Among 554 Isolates of Helicobacter pylori After Failure of Therapy. Heep, M.; Kist, M.; Strobel, S.; Beck, D.; Lehn, N. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2000, Vol. 19 Issue 7, p538 

    In a study to determine secondary resistance among Helicobacter pylori isolates, gastroenterologists from several German cities submitted over a 3-year period to centre A (Regensburg) or centre B (Freiburg) gastric biopsies from patients in whom one or more therapies to eradicate Helicobacter...

  • Recrudescence of Helicobacter pylori Infection in Patients with Healed Duodenal Ulcer after Treatment with Different Regimens. Hua-Xiang Xia; Gilvarry, Joan; Beattie, Shona; Hamilton, Hilary; Keane, Conor T.; Sweeney, Eamon C.; O'Morain, Colm A. // American Journal of Gastroenterology;Aug1995, Vol. 90 Issue 8, p1221 

    Objective: To determine the 12-month posttherapy recurrence (recrudescence) of Helicobacter pylori in patients with healed duodenal ulcer after apparent eradication of the organism with anti-H. pylori treatment. The influence of original anti-H. pylori treatment regimens on the recrudescence was...

  • Cultural Recovery and Determination of Antimicrobial Susceptibility in Helicobacter pylori by Using Commercial Transport and Isolation Media. Yuen, B.; Zbinden, R.; Fried, M.; Bauerfeind, P.; Bernardi, M. // Infection;Apr2005, Vol. 33 Issue 2, p77 

    Background: Antimicrobial resistance of Helicobacter pylori is the main reason for eradication failure. We have studied the feasibility of a commercial transport medium for cultural recovery and subsequent drug susceptibility testing. Patients and Methods: From March to December 2000, 79...

  • Metronidazole.  // Reactions Weekly;3/17/2007, Issue 1143, p18 

    This article presents a case study of meningitis that developed in a 42-year-old man during treatment with metronidazole for Helicobacter pylori infection. It discusses the clinical history of the patient and the findings of the physical and laboratory examinations conducted on the patient. It...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics